HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 186 filers reported holding HERON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,421 | -10.3% | 343,127 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $393,790 | -63.0% | 339,474 | -51.9% | 0.00% | -60.0% |
| Q1 2023 | $1,065,572 | +154.2% | 705,677 | +320.9% | 0.01% | +150.0% |
| Q4 2022 | $419,133 | -42.6% | 167,653 | -3.1% | 0.00% | -50.0% |
| Q3 2022 | $730,000 | +182.9% | 173,053 | +985.7% | 0.00% | +300.0% |
| Q1 2021 | $258,000 | -52.5% | 15,940 | -37.9% | 0.00% | -50.0% |
| Q4 2020 | $543,000 | +42.5% | 25,650 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $381,000 | +5.8% | 25,700 | +5.0% | 0.00% | 0.0% |
| Q2 2020 | $360,000 | +102.2% | 24,470 | +61.1% | 0.00% | +100.0% |
| Q1 2020 | $178,000 | -51.1% | 15,194 | +2.0% | 0.00% | -50.0% |
| Q1 2019 | $364,000 | -28.8% | 14,890 | -24.4% | 0.00% | -33.3% |
| Q4 2018 | $511,000 | +100.4% | 19,690 | +144.6% | 0.00% | +200.0% |
| Q3 2018 | $255,000 | – | 8,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |